Personalis Inc.

Last updated September 27, 2026

Organization details

Legal name
Personalis Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
8071 — Services-Medical Laboratories
Jurisdiction of incorporation
Delaware
Headquarters city
Fremont
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
PSNL
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001527753
EIN
27-5411038
Wikidata ID
Q30260685

Board of directors

Chief executives

Christopher M. Hall · President and CEO
Dates unknown

Director election results

Annual meeting of May 12, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 5 other boards. 5 are in the same sector.

Network of Personalis Inc.'s board connections Alumis Inc. Alumis Inc. Geron Corporation Geron Corporation Maze Therapeutics Inc. Maze Therapeutics Inc. QuidelOrtho Corporation QuidelOrtho Corporatio... Veracyte Inc. Veracyte Inc. Alan Colowick Alan Colowick Karin Eastham Karin Eastham Kenneth J. Widder Kenneth J. Widder Personalis Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$2,739,181
12 purchases by 1 insider
Sold, last 12 months
$8,975,205
16 sales by 4 insiders
Date Insider Transaction Shares Price Value
Nov 3, 2026 Christopher M. Hall Director, Officer (Chief Executive Officer) Open-market sale −29,112 $15.87 $462,007
Sep 18, 2026 Chen Richard Officer (President and CMO) Open-market sale −3,998 $16.22 $64,848
Sep 18, 2026 Christopher M. Hall Director, Officer (Chief Executive Officer) Open-market sale −7,459 $16.22 $120,985
Sep 18, 2026 Moore Stephen Michael Officer (SVP and Chief Legal Officer) Open-market sale −2,068 $16.22 $33,543
Sep 18, 2026 Tachibana Aaron Officer (CFO AND COO) Open-market sale −2,931 $16.22 $47,541
Jul 15, 2026 Chen Richard Officer (President and CMO) Option exercise +100,000 $2.44 $244,000
Jul 15, 2026 Chen Richard Officer (President and CMO) Open-market sale −100,000 $15.15 $1,515,000
Jul 9, 2026 Christopher M. Hall Director, Officer (Chief Executive Officer) Option exercise +100,000 $1.61 $161,000
Jul 9, 2026 Christopher M. Hall Director, Officer (Chief Executive Officer) Open-market sale −100,000 $15.08 $1,508,000
Jun 29, 2026 Tachibana Aaron Officer (CFO AND COO) Option exercise +4,982 $5.32 $26,504
Jun 29, 2026 Tachibana Aaron Officer (CFO AND COO) Open-market sale −4,982 $14.00 $69,748
Jun 26, 2026 Tachibana Aaron Officer (CFO AND COO) Option exercise +28,832 $9.16 $264,101
Jun 26, 2026 Christopher M. Hall Director, Officer (Chief Executive Officer) Option exercise +100,000 $1.61 $161,000
Jun 26, 2026 Tachibana Aaron Officer (CFO AND COO) Option exercise +22,419 $5.32 $119,269
Jun 26, 2026 Christopher M. Hall Director, Officer (Chief Executive Officer) Open-market sale −100,000 $13.15 $1,315,000

Organizations in the same sector, closest in location and size first.

Questions about Personalis Inc.

Who is the CEO of Personalis Inc.?

Christopher M. Hall is Personalis Inc.'s President and CEO.

How many directors are on Personalis Inc.'s board?

Personalis Inc.'s board has 8 directors: A. Blaine Bowman, Alan Colowick, Christopher M. Hall, Karin Eastham, Kenneth J. Widder, Lonnie Shoff, Olivia Kyusuk Bloom and Woodrow A. Myers Jr.

Are Personalis Inc. insiders buying or selling shares?

Over the last 12 months, Personalis Inc. insiders bought $2.7 million of shares in 12 purchases and sold $9.0 million of shares in 16 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="personalis-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.